The 2020 will take place virtually December 8-11. Drawing an international audience of academic and private physicians and researchers, the symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease. The Case Comprehensive Cancer Center (Case CCC) has compiled a list of spotlight sessions and posters featuring Cleveland-based institutions including Cleveland Clinic, University Hospitals and ÐÇ¿Õ´«Ã½. We wish the best of luck to all presenters and attendees!